Announced Tue, 27 Oct, 2026 · 17:42 IST
Board to approve September 2026 quarterly and half-year results
KOLTEPATIL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
The Board will meet on 3 November 2026 at 6:30 PM IST to approve unaudited standalone and consolidated results for the quarter and six months ended 30 September 2026. The filing does not disclose any financial figures.
Likely market impact
This is only a meeting notice. Financial performance and cash flow remain unknown until the results are approved and published.